GLORIA MELANIE (Chief Operating Officer) sold 0.9% of their position (2.04K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $80.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/10/2026ACC: 0001764013-26-000083
Officer· Chief Operating Officer
Since Feb 2026
-2.04K
Net shares
Net seller
$80.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.04K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.93K
Price / share
$39.53
Trade value
$76.29K
% of position
0.9%
7/8/2026
224.39K→222.46K
Common Stock
Direct
Shares
−106.00
Price / share
$39.99
Trade value
$4.24K
% of position
0.0%
7/8/2026
222.46K→222.36K
Total
Net shares
−2.04K
Net value
-$80.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2026 | S · Sale | −1.93K | $39.53 | $76.29K | 0.9% | 224.39K | 222.46K |
| Common Stock Direct | 7/8/2026 | S · Sale | −106.00 | $39.99 | $4.24K | 0.0% | 222.46K | 222.36K |
| Total | −2.04K | -$80.53K | ||||||
Derivative Transactions0
No derivative transactions reported